Cannabis Medical Program Qualifying Conditions in Mexico
Mexico uses individual case review, not a conditions list, to authorize medical cannabis through COFEPRIS.
This article is general information, not legal advice. Laws change; check current rules with official sources or a lawyer.
Mexico has no published list of 'qualifying conditions.' Instead, COFEPRIS (the federal health regulator) reviews each patient's application individually. There's no guarantee of approval even for conditions where past authorizations have been granted. The process is slow, requires a Mexican doctor and detailed medical records, and approval rates and timelines are not public. This differs sharply from U.S. state medical programs.
Legal Framework
Mexico amended its General Health Law (Ley General de Salud) in June 2017 to permit medical and scientific use of cannabis [1]. The amendment authorized the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to evaluate and approve therapeutic cannabis use under controlled conditions [1].
Mexico's system does not operate as a "qualifying conditions" list model. Instead, COFEPRIS reviews individual applications and makes determinations based on clinical evidence and medical necessity [1]. There is no published federal list of automatically approved diagnoses or conditions. Patients and physicians must submit applications to COFEPRIS for individual evaluation Strong evidence [1].
Conditions for Which Approvals Have Been Reported
COFEPRIS has not released official authorization statistics or an approved-conditions registry. However, medical advocacy organizations and patient reports suggest that approvals have been granted for epilepsy (especially refractory forms), multiple sclerosis, chronic pain, and cancer-related symptoms Weak / limited [2]. No independent verification of the distribution of approvals or claim that any condition represents a specific percentage of total authorizations is publicly available.
Crucially, approval for one patient with a given condition does not ensure approval for another patient with the same diagnosis. Each request is evaluated individually, and COFEPRIS reserves the right to deny authorization even when previous patients with the same condition have been approved Weak / limited [1].
Application Process and Requirements
Patients seeking medical cannabis authorization in Mexico generally follow this pathway [1]:
- Physician consultation: A licensed Mexican healthcare provider must evaluate the patient and determine that medical cannabis may be clinically appropriate.
- Documentation: The patient gathers medical records, diagnostic reports, and evidence of prior treatment attempts or medical reasons why conventional therapies are unsuitable.
- Submit application: The application is submitted to COFEPRIS, typically through the patient's physician or a state health authority Weak / limited [1].
- Individual review: COFEPRIS conducts a case-by-case assessment. No statutory timeline or public service standard for review exists Weak / limited.
- Authorization (if approved): If approved, the patient receives written authorization specifying the form, dose, and duration of use Weak / limited [1].
Approvals, when granted, typically specify pharmaceutical-grade cannabis products or standardized extracts rather than whole plant cannabis Weak / limited [1].
Recreational Cannabis and Legal Status
Mexico's approach to recreational cannabis differs from its medical authorization system. Mexico's Supreme Court has issued rulings that limit the federal government's ability to impose a blanket prohibition on adult personal cannabis use, and local initiatives in some states have created tolerance frameworks Weak / limited [1]. However, no comprehensive federal legalization for recreational use has been enacted.
Medical cannabis authorization is a separate federal process administered by COFEPRIS and does not depend on recreational legal status. Patients seeking legal medical cannabis must obtain COFEPRIS authorization regardless of local or informal tolerance for recreational use. Medical authorization is a distinct regulatory pathway Weak / limited [1].
For more context, see Cannabis Laws in Mexico.
International Drug Control and Cross-Border Transport
Cannabis remains classified under the United Nations Single Convention on Narcotic Drugs (1961) and related international drug control treaties Strong evidence [3]. Mexico is a signatory to these treaties.
Cross-border transport of cannabis—from Mexico to the United States, Canada, or any other country, and vice versa—is prohibited under U.S., Mexican, and Canadian federal law, regardless of authorization status in either jurisdiction. Authorized medical cannabis under Mexican law does not permit lawful import into the United States or export from Mexico to other countries Strong evidence. Attempting to transport cannabis across international borders is a serious federal crime in all countries involved.
For further reading, see UN Drug Treaties and Cannabis.
Information Gaps and What Is Not Public
Important limitations in public information about Mexico's medical cannabis system include No data:
- No authorization statistics: COFEPRIS does not publish data on the number of approvals, denials, or conditions for which authorizations have been granted.
- No published approval criteria: The specific clinical evidence standards, thresholds for "failure of conventional treatment," or decision-making framework COFEPRIS uses are not formally documented in public guidance.
- No official timeline: There is no statutory or published service standard for how long COFEPRIS takes to review applications.
- No appeal process documentation: The availability, procedures, and outcomes of appeals or reconsideration requests are not clearly detailed in public materials.
Patients and physicians seeking current information should contact COFEPRIS directly or consult a Mexican healthcare attorney with expertise in cannabis regulation.
Legal Disclaimer
This article is for informational purposes only and does not constitute legal advice. Mexican cannabis law and COFEPRIS authorization policies are subject to change. Individual authorization outcomes depend on specific medical circumstances, documentation, and regulatory discretion.
If you are considering medical cannabis authorization in Mexico:
- Consult a qualified Mexican attorney specializing in health law or cannabis regulation.
- Contact COFEPRIS directly or a licensed Mexican physician for current procedures and requirements.
- Do not rely on this article as a substitute for professional legal counsel.
Last verified: November 2026.
Sources
- Government Congreso de la Unión, Mexico (2017). Decreto por el que se reforma la Ley General de Salud en materia de cannabis terapéutico y científico. Diario Oficial de la Federación.
- Government COFEPRIS (Comisión Federal para la Protección contra el Riesgo Sanitario). Autorización de Usos Terapéuticos de Cannabis [Authorization of Therapeutic Uses of Cannabis]. Procedures and regulatory guidance.
- Government United Nations (1961). Single Convention on Narcotic Drugs. International drug control treaty.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis Laws in Mexico — Personal use decriminalized via court rulings; medical legal since 2017; no recreational m...
- Medical Cannabis for Autoimmune Conditions — Evidence for symptom relief in MS and chronic pain; no proof of disease modification.
- Medical Cannabis for Cancer Patients — Cannabis can ease chemotherapy side effects; it does not cure cancer or replace standard t...
- UN Drug Treaties and Cannabis — Three UN treaties control cannabis globally; legalization exists despite treaty language f...